Sandoz receives European Commission approval for Tyruko® (natalizumab), first and only biosimilar for multiple sclerosis in Europe

Biosimilar Tyruko® approved for all indications of reference medicine, as first and only biosimilar to treat relapsing forms of multiple sclerosis in EuropeDecision based on evidence from extensive...

Related Keywords

Switzerland ,United States ,America ,Nicole Zinsli Somm ,Richard Jarvis ,Satoshi Sugimoto ,Polpharma Biologics ,Parag Mahanti ,Sloan Simpson ,Leslie Pott ,Samir Shah ,Julie Masow ,Isabella Zinck ,Chris Lewis ,Rebecca Guntern ,Biosimilar Tyruko ,Sandoz Global Communications ,European Medicines Agency ,Facebook ,Exchange Commission ,Ms International Federation ,Instagram ,Biogen Ma Inc ,Linkedin ,European Commission ,Novartis ,Twitter ,President Europe ,Medicines Agency ,About Multiple ,Markets ,